Search Results

There are 13565 results for: content related to: Canagliflozin: Effects in overweight and obese subjects without diabetes mellitus

  1. Efficacy and safety of canagliflozin over 52 weeks in patients with type 2 diabetes mellitus and chronic kidney disease

    Diabetes, Obesity and Metabolism

    Volume 16, Issue 10, October 2014, Pages: 1016–1027, J.-F. Yale, G. Bakris, B. Cariou, J. Nieto, E. David-Neto, D. Yue, E. Wajs, K. Figueroa, J. Jiang, G. Law, K. Usiskin, G. Meininger and on behalf of the DIA3004 Study Group

    Article first published online : 22 JUL 2014, DOI: 10.1111/dom.12348

  2. You have full text access to this OnlineOpen article
    Efficacy and safety of canagliflozin over 52 weeks in patients with type 2 diabetes on background metformin and pioglitazone

    Diabetes, Obesity and Metabolism

    Volume 16, Issue 5, May 2014, Pages: 467–477, T. Forst, R. Guthrie, R. Goldenberg, J. Yee, U. Vijapurkar, G. Meininger and P. Stein

    Article first published online : 12 MAR 2014, DOI: 10.1111/dom.12273

  3. Canagliflozin improves glycaemic control over 28 days in subjects with type 2 diabetes not optimally controlled on insulin

    Diabetes, Obesity and Metabolism

    Volume 14, Issue 6, June 2012, Pages: 539–545, D. Devineni, L. Morrow, M. Hompesch, D. Skee, A. Vandebosch, J. Murphy, K. Ways and S. Schwartz

    Article first published online : 8 FEB 2012, DOI: 10.1111/j.1463-1326.2012.01558.x

  4. Effect of the sodium glucose co-transporter 2 inhibitor canagliflozin on plasma volume in patients with type 2 diabetes mellitus

    Diabetes, Obesity and Metabolism

    Volume 16, Issue 11, November 2014, Pages: 1087–1095, S. Sha, D. Polidori, T. Heise, J. Natarajan, K. Farrell, S.-S. Wang, D. Sica, P. Rothenberg and L. Plum-Mörschel

    Article first published online : 8 JUL 2014, DOI: 10.1111/dom.12322

  5. You have full text access to this OnlineOpen article
    Efficacy and safety of canagliflozin in subjects with type 2 diabetes and chronic kidney disease

    Diabetes, Obesity and Metabolism

    Volume 15, Issue 5, May 2013, Pages: 463–473, J.-F. Yale, G. Bakris, B. Cariou, D. Yue, E. David-Neto, L. Xi, K. Figueroa, E. Wajs, K. Usiskin and G. Meininger

    Article first published online : 27 MAR 2013, DOI: 10.1111/dom.12090

  6. You have full text access to this OnlineOpen article
    Efficacy and safety of canagliflozin monotherapy in subjects with type 2 diabetes mellitus inadequately controlled with diet and exercise

    Diabetes, Obesity and Metabolism

    Volume 15, Issue 4, April 2013, Pages: 372–382, K. Stenlöf, W. T. Cefalu, K.-A. Kim, M. Alba, K. Usiskin, C. Tong, W. Canovatchel and G. Meininger

    Article first published online : 24 JAN 2013, DOI: 10.1111/dom.12054

  7. You have full text access to this OnlineOpen article
    Efficacy and safety of canagliflozin in Japanese patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, 12-week study

    Diabetes, Obesity and Metabolism

    Volume 15, Issue 12, December 2013, Pages: 1136–1145, N. Inagaki, K. Kondo, T. Yoshinari, N. Maruyama, Y. Susuta and H. Kuki

    Article first published online : 14 JUL 2013, DOI: 10.1111/dom.12149

  8. You have free access to this content
    Sodium glucose co-transporter 2 inhibitors: A novel approach to the management of type 2 diabetes mellitus

    Journal of the American Association of Nurse Practitioners

    Volume 26, Issue 7, July 2014, Pages: 356–363, Courtney S. Davis, Joshua W. Fleming and , & Laurie E. Warrington

    Article first published online : 4 JUN 2014, DOI: 10.1002/2327-6924.12135

  9. Canagliflozin in Asian patients with type 2 diabetes on metformin alone or metformin in combination with sulphonylurea

    Diabetes, Obesity and Metabolism

    L. Ji, P. Han, Y. Liu, G. Yang, N. K. Dieu Van, U. Vijapurkar, R. Qiu and G. Meininger

    Article first published online : 14 OCT 2014, DOI: 10.1111/dom.12385

  10. You have full text access to this OnlineOpen article
    Efficacy and safety of canagliflozin in patients with type 2 diabetes mellitus inadequately controlled with metformin and sulphonylurea: a randomised trial

    International Journal of Clinical Practice

    Volume 67, Issue 12, December 2013, Pages: 1267–1282, J. P. H. Wilding, G. Charpentier, P. Hollander, G. González-Gálvez, C. Mathieu, F. Vercruysse, K. Usiskin, G. Law, S. Black, W. Canovatchel and G. Meininger

    Article first published online : 13 OCT 2013, DOI: 10.1111/ijcp.12322

  11. You have free access to this content
    Effect of Canagliflozin on Blood Pressure and Adverse Events Related to Osmotic Diuresis and Reduced Intravascular Volume in Patients With Type 2 Diabetes Mellitus

    The Journal of Clinical Hypertension

    Matthew R. Weir, Andrzej Januszewicz, Richard E. Gilbert, Ujjwala Vijapurkar, Irina Kline, Albert Fung and Gary Meininger

    Article first published online : 20 OCT 2014, DOI: 10.1111/jch.12425

  12. You have full text access to this OnlineOpen article
    Pharmacokinetics and Pharmacodynamics of Canagliflozin, a Sodium Glucose Co-Transporter 2 Inhibitor, in Subjects With Type 2 Diabetes Mellitus

    The Journal of Clinical Pharmacology

    Volume 53, Issue 6, June 2013, Pages: 601–610, Damayanthi Devineni, Christopher R. Curtin, David Polidori, Maria J. Gutierrez, Joseph Murphy, Sarah Rusch and Paul L. Rothenberg

    Article first published online : 14 MAY 2013, DOI: 10.1002/jcph.88

  13. Absolute oral bioavailability and pharmacokinetics of canagliflozin: A microdose study in healthy participants

    Clinical Pharmacology in Drug Development

    Accepted manuscript online: 18 SEP 2014, Damayanthi Devineni, Joseph Murphy, Shean-Sheng Wang, Hans Stieltjes, Paul Rothenberg, Ellen Scheers and Rao N.V.S. Mamidi

    DOI: 10.1002/cpdd.162

  14. Effect of canagliflozin on the pharmacokinetics of glyburide, metformin, and simvastatin in healthy participants

    Clinical Pharmacology in Drug Development

    Accepted manuscript online: 18 SEP 2014, Damayanthi Devineni, Prasarn Manitpisitkul, Joseph Murphy, Donna Skee, Ewa Wajs, Rao N.V.S. Mamidi, Hong Tian, An Vandebosch, Shean-Sheng Wang, Tom Verhaeghe, Hans Stieltjes and Keith Usiskin

    DOI: 10.1002/cpdd.166

  15. The Clinical Efficacy and Safety of Sodium Glucose Cotransporter-2 Inhibitors in Adults with Type 2 Diabetes Mellitus

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 33, Issue 9, September 2013, Pages: 984–999, Shawn Riser Taylor and Kira B. Harris

    Article first published online : 6 JUN 2013, DOI: 10.1002/phar.1303

  16. Canagliflozin, a novel inhibitor of sodium glucose co-transporter 2, dose dependently reduces calculated renal threshold for glucose excretion and increases urinary glucose excretion in healthy subjects

    Diabetes, Obesity and Metabolism

    Volume 13, Issue 7, July 2011, Pages: 669–672, S. Sha, D. Devineni, A. Ghosh, D. Polidori, S. Chien, D. Wexler, K. Shalayda, K. Demarest and P. Rothenberg

    Article first published online : 24 MAY 2011, DOI: 10.1111/j.1463-1326.2011.01406.x

  17. You have full text access to this OnlineOpen article
    Efficacy and safety of canagliflozin alone or as add-on to other oral antihyperglycemic drugs in Japanese patients with type 2 diabetes: A 52-week open-label study

    Journal of Diabetes Investigation

    Nobuya Inagaki, Kazuoki Kondo, Toru Yoshinari and Hideki Kuki

    Article first published online : 25 AUG 2014, DOI: 10.1111/jdi.12266

  18. You have full text access to this OnlineOpen article
    Effect of canagliflozin, a sodium–glucose cotransporter 2 inhibitor, on measurement of serum 1,5-anhydroglucitol (坎格列净,一种钠-葡萄糖共转运体2抑制剂,对血清1,5-脱水葡萄糖醇测定的影响)

    Journal of Diabetes

    Volume 6, Issue 4, July 2014, Pages: 378–380, Dainius A. Balis, Cindy Tong and Gary Meininger

    Article first published online : 25 FEB 2014, DOI: 10.1111/1753-0407.12116

  19. Ramping Glucosuria for Management of Type 2 Diabetes Mellitus: An Emerging Cynosure

    Medicinal Research Reviews

    Volume 34, Issue 6, November 2014, Pages: 1146–1167, Priyanka Malla, Rajnish Kumar, Manoj K. Mahapatra and Manoj Kumar

    Article first published online : 14 MAR 2014, DOI: 10.1002/med.21314

  20. Effect of canagliflozin, a sodium glucose co-transporter 2 inhibitor, on C-peptide kinetics

    Clinical Pharmacology in Drug Development

    David Polidori, Sue Sha, Tim Heise, Jaya Natarajan, Eunice Artis, Shean-Sheng Wang, Nicole Vaccaro, Paul Rothenberg and Alin Stirban

    Article first published online : 28 MAY 2014, DOI: 10.1002/cpdd.115